Morristown Medical Center’s area-based pharmacist program leads to an increase in direct patient contact and opportunities for interventions.
The COVID-19 pandemic shows that pharmacists can serve as nationally recognized providers and can contribute greatly to policy as it pertains to disease management, outbreaks, and workplace safety.
Despite triptan availability as a migraine-specific rescue, the global burden of migraine morbidity remains high.
A satisfactory system for the collection and reporting of adverse events is increasingly important as manufacturers place additional requirements on their specialty pharmacy and health care provider partners, and these needs go beyond the United States.
Health systems offer numerous opportunities for an expanded pharmacist role in integrated care delivery.
A lack of physical activity leads to a higher risk of depression among patients with rheumatic diseases.
Learn about OTC preventions for influenza, handling flu and diabetes, and more.
Patient nonadherence to medication is a well-known problem plaguing health care. For this reason, many quality measures now focus on improving adherence.
Pharmacists are routinely putting others ahead of themselves and may not be sure how to find time for self-care.
When an ACO succeeds in both delivering high-quality care and spending health care dollars more wisely, it will share in the savings it achieves for the Medicare program.
Pharmacists play a vital role in managing regimens and ensuring proper compliance.
Using the SEER-Medicare database, we found negative association between Medicare claim processors“related physician's chemotherapy reimbursement and their prescription of granulocyte colony-stimulating factor for non-Hodgkin lymphoma patients.
An Effective Treatment Plan Is Crucial for Patients with Crohn's Disease and Ulcerative Colitis.
In outpatients with type 2 diabetes mellitus, persistent exenatide treatment lowered glycated hemoglobin and hyperglycemia in both genders. Waist circumference and body weight were more reduced in women.
Major changes may be coming for the prevention of persistent migraines.
This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
As we consider the implications of the COVID-19 pandemic and the release of remdesivir, ICER’s expedited evaluation raises some questions related to value-based pricing evaluations.
Recent guidance and proposed rules for the Medicare hospice program will have a profound impact on plans providing Medicare Part D services.
Probiotics may offer a potential treatment for clostridium difficile infection.
Rising healthcare costs, lack of standardized practice and variation in practice by geographic area (including failure to follow clinical guidelines), patient nonadherence, and continued perceptions of poor value for the money that is spent continue to plague healthcare performance, according to Joshua S. Benner, PharmD, ScD, Engelberg Center for Health Care Reform, The Brookings Institution.
As healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.
Following the issuance of several emergency use authorizations by the FDA that allow at-home sample collection, it is imperative for the pharmacy team to stay abreast of current testing recommendations and limitations.
Exploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.
Amazon could leverage their advanced distribution system and consumer relationship platforms to deliver specialty pharmacy services and therapies at scale.Â
Dr. Wordell is the assistant director of Medication Use Policy, Research and Clinical Services, Department of Pharmacy, at Thomas Jefferson University Hospital.
While often overlooked, employee engagement is a key element in determining whether a hospital, health system, or pharmacy service can effectively meet its patient access, patient quality, and organizational financial demands.
This study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.